课题基金 / 基金详情

Clinical Pharmacology Analytical Core

Clinical Pharmacology Analytical Core
临床药理学分析核心
批准号:
8710487
负责人:
David R. Jones
金额:
$0.54万
依托单位国家:
美国
项目类别:
财政年份:
--
资助国家:
美国
项目状态:
已结题
起止时间:
至 2014-08-31
关键词:
African AmericanAnimalsAntineoplastic AgentsAromatase InhibitorsArtsBackBasic ScienceBiological AssayCYP2D6 geneCYP3A4 geneCancer CenterCancer Center Support GrantCancer Control ResearchCaucasiansCaucasoid RaceCell Culture TechniquesCell ExtractsChargeChildChildren&aposs Oncology GroupClinicClinicalClinical PharmacologyCollaborationsCultured CellsDataDevelopmentDevelopmental Therapeutics ProgramDisease-Free SurvivalDoseDrug ExposureDrug InteractionsDrug KineticsEnsureEnzymesEquipmentExcretory functionExemestaneFluoxetineFundingGenetic PolymorphismGermanyGoalsGrantHeadHigh Pressure Liquid ChromatographyHome environmentHospitalsHot flushesHousingHumanIn VitroIndianaIndividualItalyKoreaLabelLaboratoriesLaboratory ResearchLeadLetrozoleLightMaintenanceMalignant Childhood NeoplasmMalignant NeoplasmsMass Spectrum AnalysisMeasurementMedicineMentored Patient-Oriented Research Career Development AwardMetabolismNational Institute of General Medical SciencesNitrogenNorth Central Cancer Treatment GroupOutcomePTK787PaclitaxelParoxetinePatient CarePatientsPediatric OncologistPharmaceutical PreparationsPharmacogeneticsPharmacogenomicsPharmacology and ToxicologyPhasePhase III Clinical TrialsPlasmaPoliciesPreparationProtocols documentationPublicationsResearchResearch PersonnelResearch Project GrantsResource SharingResourcesRetrospective StudiesSaint Jude Children&aposs Research HospitalSamplingSchemeServicesSiteSpainStructureSystemTamoxifenTechnologyTimeTissue ExtractsToxic effectTranslationsUnited States National Institutes of HealthUniversitiesVariantVincristineWomanWorkabsorptionbasecancer therapycostdesigndosagegenetic varianthigh riskin vivoinhibitor/antagonistinstrumentationmalignant breast neoplasmmembermicrobial alkaline proteinase inhibitoroperationprogramsresearch studyresponsesmall moleculesquare footsuccesstrial comparingtumor

项目摘要

项目成果

David R. Jones的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
The Clinical Pharmacology Analytical Core (CPAC) assists Indiana University Simon Cancer Center (IUSCC) investigators in support of research projects and scientific goals, CPAC has been in existence since September 2004 and is the only laboratory on campus that provides investigators state-of-the-art technology to quantify small molecules, drugs, and metabolites, to identify compounds based on their mass spectra, and to analyze pharmacokinetic data. Access to state-of-the-art instrumentation for quantification of drugs and metabolites is an invaluable resource for all cancer investigators in the IUSCC. The CPAC develops and performs assays to identify and/or quantify drugs and metabolites from in vitro (including tissue extracts, cell culture and cell extracts) and in vivo studies (including humans or other animals). It also conducts pharmacokinetic analyses that describe drug (or metabolite) concentrations in the body over a period of time, from absorption to excretion, and information on drug exposure. These services ultimately assist investigators in the analysis of their research protocols regarding pharmacokinetics, pharamacodynamics, pharmacogenetics, toxicity, tumor response and identification of appropriate individualized therapies. This technology has allowed IUSCC investigators to make critical pharmacogenetic observations that are already impacting patient care.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Clinical Pharmacology Analytical Core
Clinical Pharmacology Analytical Core
Clinical Pharmacology Analytical Core
Clinical Pharmacology Analytical Core
海外基金